Research

Facilities

Our basic research facilities comprise the 2,500-square-foot Tierney Basic Sciences Research Laboratory, located on the main campus. Here, students and research faculty conduct analytical chemistry, immunology, cell and molecular biology, biochemistry and microbiology experiments. The general focus of present research is the cancer prevention and treatment, stimulation of the immune system and the chemical characterization of botanical products.

The Canadian/US Integrative Oncology Study (CUSIOS): Advanced Integrative Oncology Treatment for Patients with Advanced Stage Cancer: A Prospective Outcomes Study

An observational study describing the three-year survival outcome of advanced stage cancer patients receiving care at one of the participating integrative oncology (AIO) clinics in North America. Co-Principal Investigators: Dugald Seely, ND, MSc, FABNO – Canadian College of Naturopathic Medicine Leanna J. Standish, ND, PhD, LAc, FABNO – Bastyr University

The Bastyr Integrative Oncology Outcomes Study: Evaluating Outcomes in Patients Receiving Integrative Oncology Care (BOS)

This observational study seeks to describe the outcomes for individuals who choose to receive integrative oncology care. We will report on clinical outcomes of our patients in terms of whether cancer comes back after treatment (recurrence rates) and survival. We are also interested in identifying therapies recommended to our patients and length of hospice stay when applicable. You will not directly benefit from the study, but information gathered during the course of this study may help us begin to assess the longer-term effects of integrative naturopathic, traditional, Chinese and palliative medicine on cancer patients. To read more about this study, please click on the study title above.

Survey of Cannabis Use

Cannabis has been legalized in multiple states, both medically and recreationaly, and its use becoming more widely accepted. This survey seeks to describe the use patterns, beliefs, and any therapeutic benefits or side effects experienced by Cannabis users.

Evaluation of Quercetin in Type 2 Diabetes: Impact on Glucose Tolerance & Postprandial Endothelial Function

This study will evaluate quercitin’s effects on blood glucose and blood vessel function (endothelial function) in patients with type 2 diabetes in comparison to placebo and Acarbose, a pharmaceutical anti-diabetic agent. The study is no longer recruiting and is in data analysis phase.

Breast Cancer Integrative Oncology: Prospective Matched Controlled Outcomes Study

PURPOSE: This NIH-NCCAM funded epidemiologic research is being conducted as an observational prospective case-control study of the use of Complementary and Alternative Medicine (CAM) and Integrative Oncology (IO) and their effects on breast cancer patients in community settings. Clinicaltrials.gov: NCT-1366248. This study is ongoing but not recruiting new participants.

Michelle Sexton, ND